更多...
收起
This gene is a member of the iron/manganese superoxide dismutase family. It encodes a mitochondrial protein that forms a homotetramer and binds one manganese ion per subunit. This protein binds to the superoxide byproducts of oxidative phosphorylation and converts them to hydrogen peroxide and diatomic oxygen. Mutations in this gene have been associated with idiopathic cardiomyopathy (IDC), premature aging, sporadic motor neuron disease, and cancer. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  此基因是铁/锰超氧化物歧化酶家族的一个成员。它编码形成同源四聚体并结合每亚基1锰离子线粒体蛋白。该蛋白质结合的氧化磷酸化的超氧化物副产物,并将其转换成过氧化氢和二原子氧。在这种基因突变与特发性心肌病(IDC),早衰,散发性运动神经元疾病,和癌症相关联。备用转录剪接变体,编码不同同种型,已经表征。 [由RefSeq的,2008年7月提供]
SOD2基因(以及对应的蛋白质)的细胞分布位置:
SOD2基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6 (finding) | 0.24 | 0 | 1 | CLINVAR_CTD_human |
Esophageal Neoplasms | 0.210096888 | 7 | 0 | BeFree_CTD_human_GAD_LHGDN_RGD |
Hypertensive disease | 0.210011012 | 10 | 0 | BeFree_CTD_human_GAD_RGD |
Myocardial Infarction | 0.204734064 | 5 | 0 | CTD_human_GAD_RGD |
Diabetes Mellitus, Experimental | 0.2 | 3 | 0 | CTD_human_RGD |
Reperfusion Injury | 0.2 | 7 | 0 | CTD_human_RGD |
Aortic Aneurysm, Abdominal | 0.2 | 1 | 0 | CTD_human_RGD |
Mammary Neoplasms | 0.149524658 | 16 | 0 | BeFree_CTD_human_GAD_LHGDN |
Diabetes Mellitus, Non-Insulin-Dependent | 0.143474823 | 18 | 4 | BeFree_CTD_human_GAD |
Prostatic Neoplasms | 0.141351607 | 12 | 1 | BeFree_CTD_human_GAD_LHGDN |
Parkinson Disease | 0.132378044 | 8 | 0 | BeFree_CTD_human_GAD |
Pancreatic Neoplasm | 0.130182764 | 4 | 0 | CTD_human_GAD_LHGDN |
Liver carcinoma | 0.128729747 | 10 | 7 | BeFree_CTD_human_GAD |
Squamous cell carcinoma | 0.128630058 | 8 | 0 | BeFree_CTD_human_GAD_LHGDN |
Adenocarcinoma | 0.128358616 | 6 | 0 | BeFree_CTD_human_GAD_LHGDN |
Diabetic Nephropathy | 0.12827274 | 5 | 2 | BeFree_CTD_human_GAD_LHGDN |
Atherosclerosis | 0.127372538 | 6 | 0 | BeFree_CTD_human_GAD |
Liver Cirrhosis, Alcoholic | 0.127372538 | 3 | 0 | BeFree_CTD_human_GAD |
Mouth Neoplasms | 0.127372538 | 6 | 0 | BeFree_CTD_human_GAD |
Neoplasm Metastasis | 0.126263026 | 8 | 0 | BeFree_CTD_human_LHGDN |
Alzheimer's Disease | 0.125362824 | 3 | 0 | BeFree_CTD_human_GAD_LHGDN |
Cardiomyopathies | 0.125362824 | 2 | 0 | BeFree_CTD_human_GAD_LHGDN |
Brain Neoplasms | 0.125091382 | 3 | 0 | CTD_human_GAD_LHGDN |
Stomach Neoplasms | 0.125091382 | 5 | 0 | CTD_human_GAD_LHGDN |
Fibrosis | 0.124734064 | 3 | 0 | CTD_human_GAD |
Multiple Myeloma | 0.123267234 | 2 | 0 | BeFree_CTD_human_LHGDN |
Obesity | 0.123181358 | 5 | 2 | BeFree_CTD_human_GAD |
Colorectal Neoplasms | 0.122995792 | 4 | 0 | BeFree_CTD_human_LHGDN |
Mesothelioma | 0.122995792 | 4 | 0 | BeFree_CTD_human_LHGDN |
Rheumatoid Arthritis | 0.122909916 | 5 | 0 | BeFree_CTD_human_GAD |
Renal Cell Carcinoma | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Colonic Neoplasms | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
ovarian neoplasm | 0.12272435 | 2 | 0 | CTD_human_LHGDN |
Male infertility | 0.122638474 | 2 | 3 | BeFree_CTD_human_GAD |
Precancerous Conditions | 0.122638474 | 4 | 0 | BeFree_CTD_human_GAD |
Multiple Chemical Sensitivity | 0.122638474 | 2 | 0 | BeFree_CTD_human_GAD |
Albuminuria | 0.122367032 | 2 | 0 | CTD_human_GAD |
Pancreatic carcinoma | 0.121900093 | 8 | 6 | BeFree_CTD_human |
Amyotrophic Lateral Sclerosis | 0.121357209 | 6 | 2 | BeFree_CTD_human |
Ischemia | 0.121085767 | 6 | 0 | BeFree_CTD_human |
Kidney Diseases | 0.121085767 | 6 | 0 | BeFree_CTD_human |
Cardiomyopathy, Dilated | 0.120814326 | 5 | 2 | BeFree_CTD_human |
Degenerative polyarthritis | 0.120814326 | 5 | 0 | BeFree_CTD_human |
Major Depressive Disorder | 0.120814326 | 4 | 0 | BeFree_CTD_human |
Lung diseases | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Meningomyelocele | 0.120542884 | 2 | 0 | BeFree_CTD_human |
Osteoporosis | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Adenocarcinoma of lung (disorder) | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Squamous cell carcinoma of esophagus | 0.120542884 | 4 | 0 | BeFree_CTD_human |
Squamous cell carcinoma of the head and neck | 0.120542884 | 3 | 0 | BeFree_CTD_human |
Anemia | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Bladder Neoplasm | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Non-Small Cell Lung Carcinoma | 0.120271442 | 3 | 0 | BeFree_CTD_human |
Esophageal Stenosis | 0.120271442 | 1 | 0 | BeFree_CTD_human |
Esophagitis | 0.120271442 | 1 | 0 | BeFree_CTD_human |
Papilloma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Vascular Diseases | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Diffuse Large B-Cell Lymphoma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Myocardial Ischemia | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Adrenoleukodystrophy | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Farber Lipogranulomatosis | 0.120271442 | 1 | 0 | BeFree_CTD_human |
Neurodegenerative Disorders | 0.120271442 | 4 | 0 | BeFree_CTD_human |
Acute Coronary Syndrome | 0.120271442 | 2 | 2 | BeFree_CTD_human |
Nasopharyngeal carcinoma | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Extrinsic allergic alveolitis | 0.12 | 1 | 0 | CTD_human |
Sideroblastic anemia | 0.12 | 2 | 0 | CTD_human |
Anoxia | 0.12 | 2 | 0 | CTD_human |
Aortic Diseases | 0.12 | 1 | 0 | CTD_human |
Asphyxia Neonatorum | 0.12 | 1 | 0 | CTD_human |
Autoimmune Diseases | 0.12 | 1 | 0 | CTD_human |
Neoplastic Cell Transformation | 0.12 | 5 | 0 | CTD_human |
CNS disorder | 0.12 | 1 | 0 | CTD_human |
Brain Ischemia | 0.12 | 3 | 0 | CTD_human |
Transient Ischemic Attack | 0.12 | 1 | 0 | CTD_human |
Fatty Liver | 0.12 | 1 | 0 | CTD_human |
Fever | 0.12 | 1 | 0 | CTD_human |
Granuloma, Respiratory Tract | 0.12 | 1 | 0 | CTD_human |
Cardiomegaly | 0.12 | 1 | 0 | CTD_human |
Heart failure | 0.12 | 5 | 0 | CTD_human |
Pulmonary Hypertension | 0.12 | 1 | 0 | CTD_human |
Hyperthyroidism | 0.12 | 1 | 0 | CTD_human |
Hypoglycemia | 0.12 | 1 | 0 | CTD_human |
Insulin Resistance | 0.12 | 1 | 0 | CTD_human |
Kidney Neoplasm | 0.12 | 1 | 0 | CTD_human |
Acute Kidney Tubular Necrosis | 0.12 | 1 | 0 | CTD_human |
Lymphatic Metastasis | 0.12 | 3 | 0 | CTD_human |
Mammary Neoplasms, Experimental | 0.12 | 1 | 0 | CTD_human |
Marfan Syndrome | 0.12 | 1 | 0 | CTD_human |
Necrosis | 0.12 | 2 | 0 | CTD_human |
Neoplasm Invasiveness | 0.12 | 6 | 0 | CTD_human |
Nephrotic Syndrome | 0.12 | 1 | 0 | CTD_human |
Nerve Degeneration | 0.12 | 1 | 0 | CTD_human |
Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
Adenomatous Polyposis Coli | 0.12 | 1 | 0 | CTD_human |
Psoriasis | 0.12 | 1 | 0 | CTD_human |
Psychoses, Substance-Induced | 0.12 | 1 | 0 | CTD_human |
Sarcoidosis | 0.12 | 1 | 0 | CTD_human |
Seizures | 0.12 | 1 | 0 | CTD_human |
Shock, Cardiogenic | 0.12 | 1 | 0 | CTD_human |
Skin Abnormalities | 0.12 | 1 | 0 | CTD_human |
Dermatologic disorders | 0.12 | 1 | 0 | CTD_human |
Skin Neoplasms | 0.12 | 4 | 0 | CTD_human |
Tongue Neoplasms | 0.12 | 1 | 0 | CTD_human |
Turner Syndrome | 0.12 | 1 | 0 | CTD_human |
Uveitis | 0.12 | 2 | 0 | CTD_human |
Gestational Diabetes | 0.12 | 1 | 0 | CTD_human |
Premature Birth | 0.12 | 1 | 0 | CTD_human |
MELAS Syndrome | 0.12 | 1 | 0 | CTD_human |
Chronic progressive external ophthalmoplegia | 0.12 | 2 | 0 | CTD_human |
Lung Diseases, Interstitial | 0.12 | 1 | 0 | CTD_human |
Reticulocytosis | 0.12 | 1 | 0 | CTD_human |
Anaplastic thyroid carcinoma | 0.12 | 1 | 0 | CTD_human |
Disease Progression | 0.12 | 7 | 0 | CTD_human |
Ventricular Dysfunction, Left | 0.12 | 1 | 0 | CTD_human |
Methylmalonic acidemia | 0.12 | 1 | 0 | CTD_human |
Arsenic Poisoning | 0.12 | 1 | 0 | CTD_human |
Malignant mesothelioma | 0.12 | 1 | 0 | CTD_human |
Endotoxemia | 0.12 | 1 | 0 | CTD_human |
Necrotizing Enterocolitis | 0.12 | 1 | 0 | CTD_human |
Infarction, Middle Cerebral Artery | 0.12 | 1 | 0 | CTD_human |
Mitochondrial Diseases | 0.12 | 1 | 0 | CTD_human |
Lewy Body Disease | 0.12 | 1 | 0 | CTD_human |
Invasive Ductal Breast Carcinoma | 0.12 | 1 | 0 | CTD_human |
Cataract and cardiomyopathy | 0.12 | 1 | 0 | CTD_human |
AMYOTROPHIC LATERAL SCLEROSIS 1 | 0.080271442 | 1 | 0 | BeFree_MGD |
Cardiac Arrhythmia | 0.08 | 1 | 0 | RGD |
Bladder neck obstruction | 0.08 | 1 | 0 | RGD |
Fatty Liver, Alcoholic | 0.08 | 1 | 0 | RGD |
Sensorineural Hearing Loss (disorder) | 0.08 | 1 | 0 | RGD |
Leigh Disease | 0.08 | 0 | 0 | MGD |
Presbycusis | 0.08 | 1 | 0 | RGD |
Canavan Disease | 0.08 | 0 | 0 | MGD |
Malignant neoplasm of breast | 0.073953213 | 49 | 2 | BeFree_GAD |
Malignant neoplasm of prostate | 0.044854055 | 26 | 11 | BeFree_GAD |
Malignant neoplasm of lung | 0.021922116 | 15 | 6 | BeFree_GAD |
Schizophrenia | 0.017359805 | 13 | 1 | BeFree_GAD_LHGDN |
Malignant neoplasm of urinary bladder | 0.014549579 | 14 | 0 | BeFree_GAD |
Diabetes Mellitus, Insulin-Dependent | 0.013821129 | 9 | 2 | BeFree_GAD_LHGDN |
Age related macular degeneration | 0.013821129 | 9 | 2 | BeFree_GAD_LHGDN |
Lung Neoplasms | 0.012907115 | 4 | 1 | GAD_LHGDN |
Chronic Obstructive Airway Disease | 0.01246392 | 5 | 0 | BeFree_GAD_LHGDN |
DNA Damage | 0.01183516 | 5 | 0 | GAD |
Malignant neoplasm of ovary | 0.010553895 | 4 | 2 | BeFree_GAD |
Breast Carcinoma | 0.010314791 | 38 | 2 | BeFree |
Colorectal Cancer | 0.010282454 | 5 | 0 | BeFree_GAD |
Lymphoma, Non-Hodgkin | 0.00973957 | 5 | 0 | BeFree_GAD |
Lingual-Facial-Buccal Dyskinesia | 0.009544073 | 11 | 5 | BeFree_GAD |
Tardive Dyskinesia | 0.009544073 | 11 | 5 | BeFree_GAD |
Diabetic Retinopathy | 0.00827274 | 5 | 2 | BeFree_GAD_LHGDN |
Lupus Erythematosus, Systemic | 0.007815732 | 2 | 0 | GAD_LHGDN |
Liver neoplasms | 0.007458414 | 3 | 0 | GAD_LHGDN |
Dyskinesia, Drug-Induced | 0.007101096 | 3 | 0 | GAD |
Diabetes Mellitus | 0.00617715 | 5 | 0 | BeFree_GAD_LHGDN |
Asthma | 0.005819831 | 6 | 2 | BeFree_GAD |
Coronary Artery Disease | 0.00554839 | 5 | 2 | BeFree_GAD |
Infection | 0.0054487 | 2 | 0 | LHGDN |
Dyskinetic syndrome | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
Hepatitis C | 0.005362824 | 2 | 2 | BeFree_GAD_LHGDN |
Sepsis | 0.005362824 | 2 | 0 | BeFree_GAD_LHGDN |
Coronary heart disease | 0.005276948 | 4 | 3 | BeFree_GAD |
Behcet Syndrome | 0.005005506 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of esophagus | 0.005005506 | 3 | 0 | BeFree_GAD |
Deafness | 0.004734064 | 2 | 0 | GAD |
Diabetic Angiopathies | 0.004734064 | 2 | 1 | GAD |
Head and Neck Neoplasms | 0.004734064 | 2 | 0 | GAD |
Hearing Loss, Partial | 0.004734064 | 2 | 0 | GAD |
Inflammation | 0.004734064 | 2 | 0 | GAD |
Laryngeal neoplasm | 0.004734064 | 2 | 0 | GAD |
leukemia | 0.004734064 | 2 | 0 | GAD |
Occupational Diseases | 0.004734064 | 2 | 0 | GAD |
Pharyngeal Neoplasms | 0.004734064 | 2 | 0 | GAD |
Complications of Diabetes Mellitus | 0.004734064 | 2 | 0 | GAD |
Drug-Induced Liver Injury | 0.004734064 | 2 | 0 | GAD |
hearing impairment | 0.004734064 | 2 | 0 | GAD |
Hearing Loss | 0.004734064 | 2 | 0 | GAD |
Prostate carcinoma | 0.004614512 | 17 | 11 | BeFree |
Malignant neoplasm of pancreas | 0.004267125 | 8 | 6 | BeFree_GAD |
Malignant neoplasm of stomach | 0.003724241 | 6 | 2 | BeFree_GAD |
HIV Infections | 0.003267234 | 2 | 0 | BeFree_LHGDN |
Multiple Sclerosis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Iron Overload | 0.002995792 | 1 | 0 | BeFree_LHGDN |
Carcinoma of lung | 0.002985861 | 11 | 6 | BeFree |
Asbestosis | 0.002909916 | 2 | 0 | BeFree_GAD |
Coronary Arteriosclerosis | 0.002909916 | 3 | 2 | BeFree_GAD |
Carotid Atherosclerosis | 0.002909916 | 2 | 0 | BeFree_GAD |
Neuronal Ceroid-Lipofuscinoses | 0.00272435 | 1 | 0 | LHGDN |
Pelvic Pain | 0.00272435 | 1 | 0 | LHGDN |
Urticaria | 0.00272435 | 1 | 0 | LHGDN |
Arthritis, Reactive | 0.00272435 | 1 | 0 | LHGDN |
Sarcoma | 0.00272435 | 1 | 0 | LHGDN |
Carcinoma of bladder | 0.002714419 | 10 | 0 | BeFree |
Arthritis, Psoriatic | 0.002638474 | 1 | 0 | BeFree_GAD |
Ulcerative Colitis | 0.002638474 | 1 | 0 | BeFree_GAD |
Anterior uveitis | 0.002638474 | 1 | 0 | BeFree_GAD |
Bronchial Hyperreactivity | 0.002638474 | 1 | 0 | BeFree_GAD |
Diabetic Polyneuropathies | 0.002638474 | 2 | 0 | BeFree_GAD |
Malignant neoplasm of liver | 0.002638474 | 2 | 0 | BeFree_GAD |
Urolithiasis | 0.002638474 | 1 | 0 | BeFree_GAD |
Macroangiopathy | 0.002638474 | 2 | 0 | BeFree_GAD |
Alcoholic Intoxication, Chronic | 0.002367032 | 1 | 0 | GAD |
Angina Pectoris, Variant | 0.002367032 | 1 | 0 | GAD |
Arthritis | 0.002367032 | 1 | 0 | GAD |
Biliary Tract Neoplasm | 0.002367032 | 1 | 0 | GAD |
Choroid Diseases | 0.002367032 | 1 | 0 | GAD |
Chromosome Aberrations | 0.002367032 | 1 | 0 | GAD |
Mental Depression | 0.002367032 | 1 | 0 | GAD |
Diabetic Neuropathies | 0.002367032 | 1 | 0 | GAD |
Glaucoma, Open-Angle | 0.002367032 | 1 | 0 | GAD |
Noise-induced hearing loss | 0.002367032 | 1 | 0 | GAD |
Hypercholesterolemia | 0.002367032 | 1 | 0 | GAD |
Chronic Lymphocytic Leukemia | 0.002367032 | 1 | 0 | GAD |
Liver Cirrhosis | 0.002367032 | 1 | 0 | GAD |
Alcoholic Liver Diseases | 0.002367032 | 1 | 0 | GAD |
Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
Movement Disorders | 0.002367032 | 1 | 0 | GAD |
Neoplasms, Hormone-Dependent | 0.002367032 | 1 | 0 | GAD |
Pancreatitis | 0.002367032 | 1 | 0 | GAD |
Postoperative Complications | 0.002367032 | 1 | 0 | GAD |
Pre-Eclampsia | 0.002367032 | 1 | 0 | GAD |
Pseudoxanthoma Elasticum | 0.002367032 | 1 | 0 | GAD |
Raynaud Disease | 0.002367032 | 1 | 0 | GAD |
Varicocele | 0.002367032 | 1 | 0 | GAD |
Weight Gain | 0.002367032 | 1 | 0 | GAD |
Helicobacter Infections | 0.002367032 | 1 | 0 | GAD |
Pancreatitis, Chronic | 0.002367032 | 1 | 0 | GAD |
Disease of capillaries | 0.002367032 | 1 | 0 | GAD |
Malnutrition | 0.002367032 | 1 | 0 | GAD |
Substance-Related Disorders | 0.002367032 | 1 | 0 | GAD |
Oxidative Stress | 0.002367032 | 1 | 0 | GAD |
Cervix carcinoma | 0.002367032 | 1 | 0 | GAD |
Neuropathy | 0.002367032 | 1 | 0 | GAD |
Dermatitis and eczema | 0.002367032 | 1 | 0 | GAD |
subcutaneous fibrosis | 0.002367032 | 1 | 0 | GAD |
Hepatopulmonary Syndrome | 0.002367032 | 1 | 0 | GAD |
Chronic pelvic pain syndrome | 0.002367032 | 1 | 0 | GAD |
Radiotoxicity | 0.002367032 | 1 | 0 | GAD |
Weight Gain Adverse Event | 0.002367032 | 1 | 0 | GAD |
melanoma | 0.001900093 | 7 | 0 | BeFree |
Down Syndrome | 0.001357209 | 5 | 0 | BeFree |
Squamous cell carcinoma of tongue | 0.001357209 | 5 | 0 | BeFree |
Stomach Carcinoma | 0.001357209 | 5 | 2 | BeFree |
Diabetes | 0.001085767 | 4 | 0 | BeFree |
Ovarian Carcinoma | 0.001085767 | 4 | 2 | BeFree |
Cardiovascular Diseases | 0.000814326 | 3 | 3 | BeFree |
Colorectal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Cerebrovascular accident | 0.000814326 | 3 | 0 | BeFree |
Unipolar Depression | 0.000814326 | 3 | 0 | BeFree |
Hearing Loss, Mixed Conductive-Sensorineural | 0.000814326 | 3 | 2 | BeFree |
Carcinogenesis | 0.000814326 | 3 | 2 | BeFree |
Secondary malignant neoplasm of lymph node | 0.000814326 | 3 | 2 | BeFree |
Bipolar Disorder | 0.000542884 | 2 | 0 | BeFree |
Borderline Personality Disorder | 0.000542884 | 2 | 0 | BeFree |
Bronchopulmonary Dysplasia | 0.000542884 | 2 | 0 | BeFree |
Depressive disorder | 0.000542884 | 2 | 0 | BeFree |
Epilepsy | 0.000542884 | 2 | 2 | BeFree |
Exanthema | 0.000542884 | 2 | 0 | BeFree |
Glioma | 0.000542884 | 2 | 0 | BeFree |
Hyperglycemia | 0.000542884 | 2 | 0 | BeFree |
Neuroblastoma | 0.000542884 | 2 | 1 | BeFree |
Psychotic Disorders | 0.000542884 | 2 | 0 | BeFree |
Cataract | 0.000542884 | 2 | 0 | BeFree |
Oral Cavity Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of mouth | 0.000542884 | 2 | 0 | BeFree |
Tumor Progression | 0.000542884 | 2 | 2 | BeFree |
Lip and Oral Cavity Carcinoma | 0.000542884 | 2 | 0 | BeFree |
Glaucoma, Primary Open Angle | 0.000542884 | 2 | 0 | BeFree |
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency | 0.000542884 | 2 | 0 | BeFree |
Nonorganic psychosis | 0.000542884 | 2 | 0 | BeFree |
Chronic Kidney Insufficiency | 0.000542884 | 2 | 3 | BeFree |
Alveolitis | 0.000542884 | 2 | 0 | BeFree |
Central neuroblastoma | 0.000542884 | 2 | 1 | BeFree |
Spots on skin | 0.000542884 | 2 | 0 | BeFree |
Amyloidosis | 0.000271442 | 1 | 0 | BeFree |
Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
Ataxia | 0.000271442 | 1 | 0 | BeFree |
Rectal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of skin | 0.000271442 | 1 | 2 | BeFree |
Presenile dementia | 0.000271442 | 1 | 0 | BeFree |
Demyelinating Diseases | 0.000271442 | 1 | 2 | BeFree |
Glaucoma | 0.000271442 | 1 | 0 | BeFree |
Hamartoma Syndrome, Multiple | 0.000271442 | 1 | 0 | BeFree |
Headache | 0.000271442 | 1 | 0 | BeFree |
Heart Diseases | 0.000271442 | 1 | 0 | BeFree |
Atrial Septal Defects | 0.000271442 | 1 | 0 | BeFree |
Hemochromatosis | 0.000271442 | 1 | 0 | BeFree |
Hepatolenticular Degeneration | 0.000271442 | 1 | 0 | BeFree |
Hyperlipidemia | 0.000271442 | 1 | 0 | BeFree |
Leukomalacia, Periventricular | 0.000271442 | 1 | 0 | BeFree |
Lymphoma | 0.000271442 | 1 | 2 | BeFree |
Reticulosarcoma | 0.000271442 | 1 | 0 | BeFree |
Machado-Joseph Disease | 0.000271442 | 1 | 0 | BeFree |
Mycoses | 0.000271442 | 1 | 0 | BeFree |
Disorder of the optic nerve | 0.000271442 | 1 | 0 | BeFree |
Pain | 0.000271442 | 1 | 0 | BeFree |
Retinal Diseases | 0.000271442 | 1 | 0 | BeFree |
Retinoblastoma | 0.000271442 | 1 | 0 | BeFree |
Vitiligo | 0.000271442 | 1 | 0 | BeFree |
B-Cell Lymphomas | 0.000271442 | 1 | 3 | BeFree |
Motor Neuron Disease | 0.000271442 | 1 | 0 | BeFree |
Migraine Disorders | 0.000271442 | 1 | 1 | BeFree |
Congenital heart disease | 0.000271442 | 1 | 0 | BeFree |
Secondary malignant neoplasm of bone | 0.000271442 | 1 | 0 | BeFree |
Migraine with Aura | 0.000271442 | 1 | 2 | BeFree |
Age-related cognitive decline | 0.000271442 | 1 | 0 | BeFree |
Fibrosis, Liver | 0.000271442 | 1 | 2 | BeFree |
Qualitative abnormality of granulocyte | 0.000271442 | 1 | 0 | BeFree |
Coinfection | 0.000271442 | 1 | 0 | BeFree |
Stage IV Prostate Carcinoma | 0.000271442 | 1 | 6 | BeFree |
Very Low Birth Weight | 0.000271442 | 1 | 0 | BeFree |
Senile Plaques | 0.000271442 | 1 | 0 | BeFree |
Histiocytic sarcoma | 0.000271442 | 1 | 0 | BeFree |
Adenocarcinoma of colon | 0.000271442 | 1 | 0 | BeFree |
Common Migraine | 0.000271442 | 1 | 0 | BeFree |
Abnormal involuntary movement | 0.000271442 | 1 | 0 | BeFree |
Non-alcoholic Fatty Liver Disease | 0.000271442 | 1 | 2 | BeFree |
Dementia | 0.000271442 | 1 | 0 | BeFree |
Cerebrovascular amyloidosis | 0.000271442 | 1 | 0 | BeFree |
Bilateral cataracts (disorder) | 0.000271442 | 1 | 0 | BeFree |
Metabolic Syndrome X | 0.000271442 | 1 | 0 | BeFree |
Mood Disorders | 0.000271442 | 1 | 0 | BeFree |
Neuroleptic-Induced Tardive Dyskinesia | 0.000271442 | 1 | 0 | BeFree |
Acute anterior uveitis | 0.000271442 | 1 | 0 | BeFree |
Malignant Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
Bipolar I disorder | 0.000271442 | 1 | 0 | BeFree |
Endothelial dysfunction | 0.000271442 | 1 | 0 | BeFree |
Optic Atrophy, Hereditary, Leber | 0.000271442 | 1 | 0 | BeFree |
Skin toxicity | 0.000271442 | 1 | 0 | BeFree |
T-cell/histiocyte rich large B-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
Classical Hodgkin's Lymphoma | 0.000271442 | 1 | 0 | BeFree |
Skin Carcinogenesis | 0.000271442 | 1 | 0 | BeFree |
Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000271442 | 1 | 0 | BeFree |
Chronic Kidney Diseases | 0.000271442 | 1 | 0 | BeFree |
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.000271442 | 1 | 0 | BeFree |
Ethylmalonic encephalopathy | 0.000271442 | 1 | 0 | BeFree |
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 0.000271442 | 1 | 0 | BeFree |
Transformed migraine | 0.000271442 | 1 | 0 | BeFree |
Plaque, Amyloid | 0.000271442 | 1 | 0 | BeFree |
Stage IV Prostate Cancer AJCC v7 | 0.000271442 | 1 | 6 | BeFree |
Nonalcoholic Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
Lactic Acidosis, Fatal Infantile | 0.000271442 | 1 | 0 | BeFree |
Intellectual Disability | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。